The Resistance Mechanism of Mycoplasma bovis From Yaks in Tibet to Fluoroquinolones and Aminoglycosides
Open Access
- 2 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 840981
Abstract
Mycoplasma bovis (M. bovis) is one of the important pathogens for yaks. Aminoglycosides and fluoroquinolones are frequently used medications for the treatment of M. bovis. Drug-resistant strains were inevitable with the abuse of antibiotics. The resistance of M. bovis to aminoglycosides was related to the base mutations in drug target genes. Amino acid mutations at the quinolone resistance-determining region (QRDR) in gyrA, gyrB, parC, and parE conferred resistance to fluoroquinolones. In order to investigate the resistance mechanism of M. bovis from yaks in Tibet to aminoglycosides and fluoroquinolones, six frequently used antibiotics and ten clinical M. bovis strains were administered for a drug sensitivity test for in vitro-induced highly resistant strains, a drug stable-resistance test, cross-resistance test, and analysis of target gene mutations. The results showed that the clinical strains of M. bovis from yaks in Tibet had varying degrees of resistance to fluoroquinolones and aminoglycosides. The mechanism of resistance to fluoroquinolones and aminoglycosides was identified preliminarily for M. bovis from yaks: the single-site base mutation mediated the resistance of M. bovis from yaks and both base mutations led to highly resistant strains (aminoglycosides: rrs3 and rrs4; fluoroquinolones: gyrA and parC). The active efflux system results of M. bovis showed that there was no active efflux system based on fluoroquinolones and aminoglycosides expressed in M. bovis from yaks. The research could provide a reference for clinical treatment of M. bovis.Keywords
This publication has 17 references indexed in Scilit:
- Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be EqualApplied and Environmental Microbiology, 2016
- 16S rRNA Gene Mutations Associated with Decreased Susceptibility to Tetracycline in Mycoplasma bovisAntimicrobial Agents and Chemotherapy, 2015
- Resistance of M. leprae to Quinolones: A Question of Relativity?PLOS Neglected Tropical Diseases, 2013
- Amino Acid Substitutions in GyrA and ParC are Associated with Fluoroquinolone Resistance in Mycoplasma bovis Isolates from Japanese Dairy CalvesJournal of Veterinary Medical Science, 2013
- Mycoplasma bovis Infections in CattleJournal of Veterinary Internal Medicine, 2011
- Rapid Detection of a Point Mutation in the parC Gene Associated with Decreased Susceptibility to Fluoroquinolones in Mycoplasma bovisAntimicrobial Agents and Chemotherapy, 2009
- The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlotsThe Veterinary Journal, 2008
- Mutations in 16S rRNA and Ribosomal Protein S5 Associated with High-Level Spectinomycin Resistance in Pasteurella multocidaAntimicrobial Agents and Chemotherapy, 2007
- Mycoplasma bovis: disease, diagnosis, and controlResearch in Veterinary Science, 2003
- Sequence Polymorphism in the rrs Gene of Mycobacterium tuberculosis Is Deeply Rooted within an Evolutionary Clade and Is Not Associated with Streptomycin ResistanceJournal of Clinical Microbiology, 2001